BTMD
BTMD
US0906831039
Biote Corp.
Loading chart...

Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Latest News

Related stocks

GMRS
GMRS • United States
GMR Solutions Inc.
10.38 USD
560.75M USD
PIII
PIII • United States
P3 Health Partners Inc.
4.95 USD
1.01B USD 1Y -40.7%
NUTX
NUTX • United States
Nutex Health Inc.
206.29 USD
1.41B USD 1Y +99.5%
SGRY
SGRY • United States
Surgery Partners, Inc.
13.89 USD
1.82B USD 1Y -33.7%
PNTG
PNTG • United States
The Pennant Group, Inc.
39.73 USD
1.39B USD 1Y +59.6%
USPH
USPH • United States
U.S. Physical Therapy, Inc.
84.67 USD
1.26B USD 1Y -7.6%
TOI
TOI • United States
The Oncology Institute, Inc.
5.13 USD
512.91M USD
AVAH
AVAH • United States
Aveanna Healthcare Holdings Inc
12.25 USD
2.67B USD 1Y +36.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
71.0% p.a.
Max Drawdown (5Y)
-89.0%
Sharpe Ratio (5Y)
-0.52
Beta Factor
1.69
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
High market risk: Beta of 1.69 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (71.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -89.0% in the extended horizon.
ende